Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
Medincell's Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris®
02:00am, Monday, 23'rd Sep 2024
MONTPELLIER, France--(BUSINESS WIRE)--New data presented by Teva at ECNP 2024* demonstrate switching to UZEDY at four weeks after the last dose of once-monthly Perseris® (RBP-7000) provided the most
TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label ext
TEL AVIV, Israel & PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new positiv
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today presented data info
Teva Pharmaceutical Industries Limited (TEVA) Bank of America Global Healthcare Conference (Transcript)
10:25am, Thursday, 19'th Sep 2024
Teva Pharmaceuticals Industries Limited (NYSE:TEVA ) Bank of America Global Healthcare Conference September 18, 2024 3:15 AM ET Company Participants Richard Francis - President & CEO Conference Call P
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
04:00pm, Friday, 13'th Sep 2024
Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested.
Teva to Present at the Bank of America 2024 Global Healthcare Conference
04:30pm, Wednesday, 11'th Sep 2024
TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Bank
Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial
04:24pm, Tuesday, 10'th Sep 2024
Baltimore said on Tuesday that it has settled with Walgreens over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5
Exclusive: Teva faces EU fine for disparaging rival multiple sclerosis medicine, sources say
11:46am, Tuesday, 10'th Sep 2024
Teva , the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone, people
Cheap Teva Stock Should Reward Patient Investors
01:29pm, Monday, 09'th Sep 2024
Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. The company's valuation is attractive despite its high debt load, which it is likely
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
01:46pm, Friday, 06'th Sep 2024
JP Morgan notes that while there's a resurgence of interest and excitement in new product launches within the specialty group, including branded and complex generics/biosimilars, investors should be d
Medincell's Partner Teva Provides New Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI)
01:30am, Thursday, 05'th Sep 2024
MONTPELLIER, France--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced during the 22nd Annual Global Healthcare Conference
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
10:48pm, Wednesday, 04'th Sep 2024
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Morgan Stanley 22nd Annual Global Healthcare Conference Call September 4, 2024 11:30 AM ET Company Participants Richard Francis - Chief Executive Of
2 Reasonably Priced Stocks to Keep an Eye On
03:18pm, Thursday, 29'th Aug 2024
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Hewlett Packard Enterprise Co (NYSE:HPE) are this week's picks for Schaeffer's Cheap Seats : Stocks Under $20 segment.
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
05:00pm, Monday, 26'th Aug 2024
TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Morgan
